These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10386192)
1. A study of platelet serotonin receptor in mania. Velayudhan A; Sunitha TA; Balachander S; Reddy JY; Khanna S Biol Psychiatry; 1999 Apr; 45(8):1059-62. PubMed ID: 10386192 [TBL] [Abstract][Full Text] [Related]
2. A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors in healthy humans. Yatham LN; Steiner M; Liddle PF; Shiah IS; Lam RW; Zis AP; Coote M Psychopharmacology (Berl); 2000 Sep; 151(4):424-7. PubMed ID: 11026749 [TBL] [Abstract][Full Text] [Related]
3. Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets. McBride PA; Mann JJ; Polley MJ; Wiley AJ; Sweeney JA Life Sci; 1987 May; 40(18):1799-809. PubMed ID: 3573979 [TBL] [Abstract][Full Text] [Related]
4. 5-HT2 serotonin receptor on blood platelet of migraine patients. Govitrapong P; Limthavon C; Srikiatkhachorn A Headache; 1992 Nov; 32(10):480-4. PubMed ID: 1468904 [TBL] [Abstract][Full Text] [Related]
5. Platelet serotonin and serum lipids in psychotic mania. Sagud M; Mihaljevic-Peles A; Pivac N; Jakovljevic M; Muck-Seler D J Affect Disord; 2007 Jan; 97(1-3):247-51. PubMed ID: 16820211 [TBL] [Abstract][Full Text] [Related]
6. Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment. Pandey GN; Pandey SC; Ren X; Dwivedi Y; Janicak PG Psychopharmacology (Berl); 2003 Nov; 170(2):115-23. PubMed ID: 12845409 [TBL] [Abstract][Full Text] [Related]
7. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. Lyon RA; Davis KH; Titeler M Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649 [TBL] [Abstract][Full Text] [Related]
8. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone. Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776 [TBL] [Abstract][Full Text] [Related]
9. Platelet 3H ketanserin binding in migraine. Shukla R; Khanna VK; Pradeep S; Husain M; Tandon R; Nag D; Dikshit M; Srimal RC; Seth PK Cephalalgia; 2001 Jun; 21(5):567-72. PubMed ID: 11472383 [TBL] [Abstract][Full Text] [Related]
10. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment. Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499 [TBL] [Abstract][Full Text] [Related]
11. Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Pandey GN; Pandey SC; Dwivedi Y; Sharma RP; Janicak PG; Davis JM Am J Psychiatry; 1995 Jun; 152(6):850-5. PubMed ID: 7755113 [TBL] [Abstract][Full Text] [Related]
12. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation. Pinto W; Battaglia G Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431 [TBL] [Abstract][Full Text] [Related]
13. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin. Leysen JE; Gommeren W; De Clerck F Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103 [TBL] [Abstract][Full Text] [Related]
14. Serotonin 5-HT2 receptor binding on blood platelets--a peripheral marker for depression? Biegon A; Weizman A; Karp L; Ram A; Tiano S; Wolff M Life Sci; 1987 Nov; 41(22):2485-92. PubMed ID: 3683087 [TBL] [Abstract][Full Text] [Related]
15. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial. Akhondzadeh S; Mohajari H; Reza Mohammadi M; Amini H BMC Psychiatry; 2003 Jun; 3():7. PubMed ID: 12816549 [TBL] [Abstract][Full Text] [Related]
16. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353 [TBL] [Abstract][Full Text] [Related]
17. Platelet 5-HT2 serotonin receptor binding sites in autistic children and their first-degree relatives. Perry BD; Cook EH; Leventhal BL; Wainwright MS; Freedman DX Biol Psychiatry; 1991 Jul; 30(2):121-30. PubMed ID: 1912104 [TBL] [Abstract][Full Text] [Related]
18. 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration. Twist EC; Mitchell S; Brazell C; Stahl SM; Campbell IC Biochem Pharmacol; 1990 Jan; 39(1):161-6. PubMed ID: 1688704 [TBL] [Abstract][Full Text] [Related]
19. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Cook EH; Arora RC; Anderson GM; Berry-Kravis EM; Yan SY; Yeoh HC; Sklena PJ; Charak DA; Leventhal BL Life Sci; 1993; 52(25):2005-15. PubMed ID: 7684805 [TBL] [Abstract][Full Text] [Related]
20. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites. Pinto W; Battaglia G Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]